Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Clinical trials in Lafayette, LA: what is studied
Cancer. The Cancer Center of Acadiana and local urology practices take part in cancer studies, including prostate cancer and bladder cancer; see our oncology clinical trials page.
Digestive diseases. The Gastroenterology Clinic of Acadiana takes part in studies for Crohn's disease, ulcerative colitis, and other digestive conditions.
Vaccines and healthy volunteers. Vaccine studies recruit in Lafayette, and some local studies accept healthy volunteers. If you have never taken part in research, our guide explains how to volunteer for clinical trials.
Other conditions. Studies in heart disease, asthma, COPD, wound care, and weight loss also recruit in the area.
Paid clinical trials in Lafayette and Acadiana
Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything. Payments are reviewed by the institutional review board that oversees the study, and under FDA guidance they are usually paid out over the course of the study rather than only at the end. Many studies at least cover travel, which helps if you are coming from elsewhere in Acadiana.
Our guide explains how much clinical trials pay and how payment is decided.
Clinical trials in New Iberia, Eunice, and across Acadiana
Some studies recruit at research sites in smaller Acadiana towns such as New Iberia and Eunice, and studies at those sites appear on this page alongside those in Lafayette. For larger hospital programs, see our Baton Rouge page, about an hour east, and our New Orleans page, or browse all Louisiana clinical trials.
How to join a clinical trial in Lafayette
- Identify your trial. Use the filters on this page to narrow the list by condition or phase, or search a diagnosis such as Crohn's disease or prostate cancer.
- Check the location. Each study lists the sites where it recruits, so confirm it has a site in Lafayette or a nearby town such as New Iberia or Eunice.
- Explore study details. Read the eligibility criteria and, where listed, the number of visits and how long the study lasts before applying.
- Complete the health profile. Click "See if you qualify" to begin the 5-step application. Have ready your diagnosis and when it was made, the medicines you take, and any recent test results.
- Submit the application. A clinical trial coordinator reviews it and contacts you to discuss next steps. Nothing is decided until informed consent, and participation is voluntary at every step.
Our guide to finding clinical trials near you covers each step in more detail.
Can I leave a clinical trial after I join?
Yes. Participation is voluntary, and you can leave a study at any time without affecting your regular medical care. The study team may ask you to come for a final safety visit. Our guide explains informed consent and your rights as a participant.